Clinical Trial Update: Open Label Study to Evaluate the Activity of Imetelstat in Patients With Essential Thrombocythemia or Polycythemia Vera [Phase 2]

View source ↗

Summary

An open-label Phase 2 trial evaluating imetelstat in essential thrombocythemia or polycythemia vera has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Thrombocythemia
• Polycythemia Vera

Drugs mentioned

• Imetelstat (imetelstat)

Snippet

Sponsor: Geron Corporation | Conditions: Essential Thrombocythemia, Polycythemia Vera | Phase 2 | Status: COMPLETED